Middle East Fertility Society Journal
Volume 16, Issue 4 , Pages 254-256 , December 2011

GnRH antagonist for pituitary desensitization in IVF: Is it a time for a change of practice?

Received 20 October 2011 ,Accepted 1 November 2011.

References 

  1. Porter RN, et al. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet. 1984;2(8414):1284–1285
  2. Albuquerque LE, Saconato H, Maciel MC. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Cochrane Database Syst Rev. 2005;1:CD002808
  3. Kondaveeti-Gordon U, et al. A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program. Fertil Steril. 1996;66(4):582–586
  4. Qublan HS, Amarin Z, Tahat YA, Smadi AZ, Kilani M. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Hum Reprod. 2006;21(3):640–644
  5. Mancini F, et al. Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2011;27(3):150–155
  6. Hsieh YY, Chang CC, Tsai HD. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization. Taiwan J Obstet Gynecol. 2009;47(1):66–74
  7. Ekerhovd E. Use of GnRH antagonist for in vitro fertilization. Tidsskr Nor Laegeforen. 2011;131(17):1649–1652
  8. Gilliam ML. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Obstet Gynecol. 2011;118(3):706–707
  9. Garcia-Velasco JA, Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome. Current opinion in obstetrics & Gynecoogy. 2003;15:251–256
  10. Garcia-Velasco JA, Isaza V, Quea G, Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing. Fertil Steril. 2006;85:547–554
  11. Youssef MA, Al-Inany HG, Evers JL, Aboulghar M. Intra-venous fluids for the prevention of severe ovarian hyperstimulation Syndrome. Cochrane Database Syst Rev. 2011;16(2):CD001302
  12. Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011;19(1):CD008046
  13. Youssef MA, van Wely M, Hassan MA, Al-Inany HG, Mochtar M, Khattab S, et al. Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis. Hum Reprod Update. 2010;16(5):459–466
  14. Loutradis D, Kiapekou E, Zapanti E, Antsaklis A. Oocyte maturation in assisted reproductive techniques. Ann N Y Acad Sci. 2006;1092:235–246
  15. Al-Inany HG, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;5:CD001750
  16. Fauser BC, et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod. 1999;14(11):2681–2686
  17. Fatemi H, Kolibianakis EM, Camus M, Tournaye H, Van Steirteghem A. Devroey P progesterone versus progesterone combined with estradiol as luteal support in cycles stimulated with GnRH antagonist/rec-FSH for IVF: a randomized clinical trial. Fertil Steril. 2005;84(Supplement 1):S322
  18. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril. 2010;94(6):2382–2384
  19. Bonduelle M, et al. Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation. Hum Reprod. 2010;25(6):1433–1440
  20. Lainas TG, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Hum Reprod. 2010;25(3):683–689

PII: S1110-5690(11)00108-7

doi: 10.1016/j.mefs.2011.11.001

Middle East Fertility Society Journal
Volume 16, Issue 4 , Pages 254-256 , December 2011

Article Tools

* Image Usage & Resolution